CSE:MBIO - Post Discussion
Post by
Smokey1958 on Feb 28, 2024 9:11am
Ahead of the Game
If the following document is any indication MBio appears to be ahead of the game. As this document on FDA expectations for drug trials, released in June 2023, is in draft only it is unlikely trials will begin in the US anytime soon. In fact readers of the document had 60 days to provide written comment and suggested revisions.
If MBio continues its trajectory of trials including increasing the numbers of participants and refining procedures as necessary to eliminate bias in conclusions they should remain well ahead of the curve for the foreseeable future. This is notwithstanding the addition of capital through investment by governments and publicly.
https://www.fda.gov/media/169694/download
Be the first to comment on this post